aTyr Pharma Inc expected to post a loss of 40 cents a share - Earnings Preview

aTyr Pharma

05/05/2023 12:29

* aTyr Pharma Inc  LIFE.OQ   LIFE.O  is expected to show a
rise in
quarterly revenue when it reports  results on May 8
(estimated). 
    * The San Diego California-based  company is expected to
report
revenue of $303.33 thousand, according to the mean estimate from
6 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for aTyr Pharma Inc is
for a
loss of 40 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 1.1%
in the last three months. ​
    * Wall Street's median 12-month price target for aTyr Pharma
Inc
is $17​, above​ its last closing price of $2.05. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.48       -0.48      -0.26     Beat    45.8
 Sep. 30 2022  -0.45       -0.46      -0.46     Met     0.4
 Jun. 30 2022  -0.39       -0.38      -0.44     Missed  -15.2​
 Mar. 31 2022  -0.33       -0.33      -0.44     Missed  -32.7
 ​​Dec.                    -0.28      -0.31     Missed  -9.4
 31 2021                                                
 Sep. 30 2021  -0.65       -0.60      -0.42     Beat    29.5​
 Jun. 30 2021  -0.50       -0.51      -0.64     Missed  -26
 Mar. 31 2021  -0.40       -0.32      -0.51     Missed  -60.6
 This summary was machine generated May 5 at 11:29 GMT.  All
figures in US dollars  unless otherwise stated